International Journal of Radiation Oncology * Biology * Physics
Volume 77, Issue 5 , Pages 1477-1485 , 1 August 2010

Radiation-Induced Cancers From Modern Radiotherapy Techniques: Intensity-Modulated Radiotherapy Versus Proton Therapy

Received 18 March 2009 ,Revised 3 July 2009 ,Accepted 3 July 2009.

References 

  1. Bush DA, Slater JD, Bonnet R, et al. Proton-beam radiotherapy for early-stage lung cancer. Chest. 1999;116:1313–1319
  2. Fowler JF. What can we expect from dose escalation using proton beams?. Clin Oncol (R Coll Radiol). 2003;15:S10–S15
  3. Kagei K, Tokuuye K, Sugahara S, et al. [Initial experience of proton beam therapy at the new facility of the University of Tsukuba.] Nippon Igaku Hoshasen Gakkai Zasshi. 2004;64:225–230
  4. Tsujii H, Tsuji H, Inada T, et al. Clinical results of fractionated proton therapy. Int J Radiat Oncol Biol Phys. 1993;25:49–60
  5. Schneider U, Lomax A, Lombriser N. Comparative risk assessment of secondary cancer incidence after treatment of Hodgkin's disease with photon and proton radiation. Radiat Res. 2000;154:382–388
  6. Hall EJ. Intensity-modulated radiation therapy, protons, and the risk of second cancers. Int J Radiat Oncol Biol Phys. 2006;65:1–7
  7. Macklis R. In regard to Hall: Intensity-modulated radiation therapy, protons, and the risk of second cancers (Int J Radiat Oncol Biol Phys 2006;65:1–7). Int J Radiat Oncol Biol Phys. 2006;66:1593–1594author reply 1595
  8. Gottschalk B. Neutron dose in scattered and scanned proton beams: In regard to Hall EJ (Int J Radiat Oncol Biol Phys 2006;65:1–7). Int J Radiat Oncol Biol Phys. 2006;66:1594;author reply 1595
  9. Paganetti H, Bortfeld T, Delaney TF. Neutron dose in proton radiation therapy: In regard to Hall EJ (Int J Radiat Oncol Biol Phys 2006;65:1–7). Int J Radiat Oncol Biol Phys. 2006;66:1594–1595author reply 1595
  10. Binns PJ, Hough JH. Secondary dose exposures during 200 MeV proton therapy. Radiat Prot Dosimetry. 1997;70:441–444
  11. Mesoloras G, Sandison GA, Stewart RD, et al. Neutron scattered dose equivalent to a fetus from proton radiotherapy to the mother. Med Phys. 2006;33:2479–2490
  12. Agosteo S, Birattari C, Caravaggio M, et al. Secondary neutron and photon dose in proton therapy. Radiother Oncol. 1998;48:293–305
  13. Fontenot JD, Newhauser WD, Titt U. Design tools for proton therapy nozzles based on the double-scattering foil technique. Radiat Prot Dosimetry. 2005;116:211–215
  14. Jiang H, Wang B, Xu XG, et al. Simulation of organ-specific patient effective dose due to secondary neutrons in proton radiation treatment. Phys Med Biol. 2005;50:4337–4353
  15. Polf JC, Newhauser WD. Calculations of neutron dose equivalent exposures from range-modulated proton therapy beams. Phys Med Biol. 2005;50:3859–3873
  16. Polf JC, Newhauser WD, Titt U. Patient neutron dose equivalent exposures outside of the proton therapy treatment field. Radiat Prot Dosimetry. 2005;115:154–158
  17. Roy SC, Sandison GA. Scattered neutron dose equivalent to a fetus from proton therapy of the mother. Radiat Phys Chem. 2004;71:997–998
  18. Schneider U, Agosteo S, Pedroni E, et al. Secondary neutron dose during proton therapy using spot scanning. Int J Radiat Oncol Biol Phys. 2002;53:244–351
  19. Schneider U, Fiechtner A, Besserer J, et al. Neutron dose from prostheses material during radiotherapy with protons and photons. Phys Med Biol. 2004;49:N119–N124
  20. Tayama R, Fujita Y, Tadokoro M, et al. Measurement of neutron dose distribution for a passive scattering nozzle at the Proton Medical Research Center (PMRC). Nucl Instrum Methods Phys Res A. 2006;564:532–536
  21. Wroe A, Rosenfeld A, Schulte R. Out-of-field dose equivalents delivered by proton therapy of prostate cancer. Med Phys. 2007;34:3449–3456
  22. Yan X, Titt U, Koehler AM, et al. Measurement of neutron dose equivalent to proton therapy patients outside of the proton radiation field. Nucl Instrum Methods Phys Res A. 2002;476:429–344
  23. Zheng Y, Newhauser W, Fontenot J, et al. Monte Carlo study of neutron dose equivalent during passive scattering proton therapy. Phys Med Biol. 2007;52:4481–4496
  24. Hall EJ, Wuu C. Radiation-induced second cancers: The impact of 3D-CRT and IMRT. Int J Radiat Oncol Biol Phys. 2003;56:83–88
  25. Schneider U, Zwahlen D, Ross D, et al. Estimation of radiation-induced cancer from three-dimensional dose distributions: Concept of organ equivalent dose. Int J Radiat Oncol Biol Phys. 2005;61:1510–1515
  26. Schneider U, Lomax A, Timmermann B. Second cancers in children treated with modern radiotherapy techniques. Radiother Oncol. 2008;89:135–140
  27. Gray LH. Radiation biology and cancer. In: Cellular radiation biology: A symposium considering radiation effects in the cell and possible implications for cancer therapy. Baltimore: William & Wilkins; 1965;p. 8–25
  28. Boice JD, Day NE, Anderson A. Second cancers following radiation treatment for cervical cancer. An international collaboration among cancer registries. J Natl Cancer Inst. 1985;74:955–975
  29. Brenner DJ, Curtis RE, Hall EJ, et al. Second malignances in prostate patients after radiotherapy compared with surgery. Cancer. 2000;88:398–406
  30. Pierce DA, Shimizu Y, Preston DL, et al. Studies of the mortality of atomic bomb survivors. Report 12, part I. Cancer: 1950-1990. Radiat Res. 1996;146:1–27

 Supported by Grant A080756 from the Korea Healthcare Technology R&D Project, Ministry of Health, Welfare and Family Affairs, Republic of Korea; and Research Grant 0910180 from the National Cancer Center, Korea.

 Conflict of interest: none.

PII: S0360-3016(09)01028-1

doi: 10.1016/j.ijrobp.2009.07.011

International Journal of Radiation Oncology * Biology * Physics
Volume 77, Issue 5 , Pages 1477-1485 , 1 August 2010

Article Tools

* Image Usage & Resolution